A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
Clinical trial NCT06328049 · UNKNOWN
Trial details
- NCT number
- NCT06328049
- Sponsor
- Taixing People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2025-02-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.